Patent ID: 9346805
Filing Date: 2016-05-24
CPC Classification: A61P,C07D

Claim Text:
1. A method of inhibiting Akt-1 protein kinase for treating or lessening the severity of a cancer in a patient, comprising administering to said patient a therapeutically effective amount of a compound of Formula I: and tautomers, resolved enantiomers, resolved diastereomers, metabolites, salts and pharmaceutically acceptable prodrugs thereof, wherein: R R R each R R R R two R R two R m and n are independently 1, 2 or 3, provided that m and n taken together are 3, 4 or 5; p is 0, 1, 2 or 3; and each t is independently 0, 1, 2, 3 or 4.